chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus, Vaccination site pain
Clinical narrative: Mild sensation of ringing in the ear (before 2nd dose); sore  after 1st arm dose; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Mild sensation of ringing in the ear (before 2nd dose)) and VACCINATION SITE PAIN (sore  after 1st arm dose) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No medical history and concomitant drug information provided by reporter.     On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Mild sensation of ringing in the ear (before 2nd dose)) and VACCINATION SITE PAIN (sore  after 1st arm dose). At the time of the report, TINNITUS (Mild sensation of ringing in the ear (before 2nd dose)) and VACCINATION SITE PAIN (sore  after 1st arm dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history and concomitant drug information provided by reporter.   This case was linked to MOD-2021-248516 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Insomnia, Pain in extremity, Rash macular, Scab
Clinical narrative: ringing in the ear worse ( after 2nd dose); blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab; couldn't fall asleep; blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab; ringing in the ear worse; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in the ear worse ( after 2nd dose)), CONDITION AGGRAVATED (ringing in the ear worse), PAIN IN EXTREMITY (sore arm), RASH MACULAR (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) and SCAB (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009021A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In June 2021, the patient experienced CONDITION AGGRAVATED (ringing in the ear worse), PAIN IN EXTREMITY (sore arm) and SCAB (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab). On 18-Jun-2021, the patient experienced TINNITUS (ringing in the ear worse ( after 2nd dose)), RASH MACULAR (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) and INSOMNIA (couldn't fall asleep). At the time of the report, TINNITUS (ringing in the ear worse ( after 2nd dose)) and CONDITION AGGRAVATED (ringing in the ear worse) had not resolved, PAIN IN EXTREMITY (sore arm), RASH MACULAR (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) and SCAB (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) had resolved and INSOMNIA (couldn't fall asleep) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided by reporter.   This case was linked to MOD-2021-248502 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing in the ear worse ( after 2nd dose); blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab; couldn't fall asleep; blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab; ringing in the ear worse; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in the ear worse ( after 2nd dose)), CONDITION AGGRAVATED (ringing in the ear worse), PAIN IN EXTREMITY (sore arm), RASH MACULAR (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) and SCAB (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009021A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In June 2021, the patient experienced CONDITION AGGRAVATED (ringing in the ear worse), PAIN IN EXTREMITY (sore arm) and SCAB (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab). On 18-Jun-2021, the patient experienced TINNITUS (ringing in the ear worse ( after 2nd dose)), RASH MACULAR (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) and INSOMNIA (couldn't fall asleep). At the time of the report, TINNITUS (ringing in the ear worse ( after 2nd dose)) and CONDITION AGGRAVATED (ringing in the ear worse) had not resolved, PAIN IN EXTREMITY (sore arm), RASH MACULAR (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) and SCAB (blood clot blotches on the back of both hands which one clot was ripped and resulted in a scab) had resolved and INSOMNIA (couldn't fall asleep) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided by reporter.   This case was linked to MOD-2021-248502 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Hair falling out; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair falling out) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Hair falling out). At the time of the report, ALOPECIA (Hair falling out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was reported.   Reporter did not allow further contact
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was reported.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient has received 1st dose on 21st May and hasn't received 2nd dose yet past 42 days) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination. No medical history was provided by the reporter. On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has received 1st dose on 21st May and hasn't received 2nd dose yet past 42 days). On 21-May-2021, PRODUCT DOSE OMISSION ISSUE (Patient has received 1st dose on 21st May and hasn't received 2nd dose yet past 42 days) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications include 2 Blood Pressure Medicines. No treatment information was reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore left injection site arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced VACCINATION SITE PAIN (Sore left injection site arm). At the time of the report, VACCINATION SITE PAIN (Sore left injection site arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.   This case was linked to MOD-2021-248562 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: first dose >35 days ago; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Jul-2021 and was forwarded to Moderna on 07-Jul-2021.    This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose >35 days ago) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose >35 days ago). In January 2021, PRODUCT DOSE OMISSION ISSUE (first dose >35 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatments were provided.   Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Malaise
Clinical narrative: Feeling Sick; No energy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling Sick), ASTHENIA (No energy) and HEADACHE (Headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009D21A and 038C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced MALAISE (Feeling Sick), ASTHENIA (No energy) and HEADACHE (Headache). On 27-Jun-2021, MALAISE (Feeling Sick) and ASTHENIA (No energy) had resolved. At the time of the report, HEADACHE (Headache) had not resolved.            No relevant concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-248548 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). On 05-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: second dose has not been given and more than 35 days o administration of the first dose have passed; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Jul-2021 and was forwarded to Moderna on 06-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second dose has not been given and more than 35 days o administration of the first dose have passed) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cancer.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose has not been given and more than 35 days o administration of the first dose have passed). On 08-Apr-2021, PRODUCT DOSE OMISSION ISSUE (second dose has not been given and more than 35 days o administration of the first dose have passed) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included diabetic medications, not otherwise specified.  Treatment information was not provided.  The reporter stated that the patient went to see her mother and did not attend the appointment. And lost her vaccination card. Patient tested negative for COVID-19 4 times.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Has not received the second dose > 3 months after the First dose; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Has not received the second dose > 3 months after the First dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Has not received the second dose > 3 months after the First dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Has not received the second dose > 3 months after the First dose) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. No concomitant drug information was reported. No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Given expired vaccine; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       HCP stated that vaccine was received on 28-May-2021 and it was used on 27-Jun-2021 once it was refrigerated. She added that the vaccine was never used until the vial was used on twenty patients. She stated that she read about the vaccine being stable for 90 days. She wanted to know if the data supports what she read online about product stability and how long after the 30-day expiration date is the vaccine stable.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Urticaria
Clinical narrative: Patient has not received 2nd dose due to side effect experienced, 1st dose given 18May2021; red welts all over body head to toe; This spontaneous case was reported by a health care professional and describes the occurrence of URTICARIA (red welts all over body head to toe) and PRODUCT DOSE OMISSION ISSUE (Patient has not received 2nd dose due to side effect experienced, 1st dose given 18May2021) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (red welts all over body head to toe) and PRODUCT DOSE OMISSION ISSUE (Patient has not received 2nd dose due to side effect experienced, 1st dose given 18May2021). At the time of the report, URTICARIA (red welts all over body head to toe) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Patient has not received 2nd dose due to side effect experienced, 1st dose given 18May2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medication was supplements but was unsure of which. The treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up received on 6-JUL-2021 and contains non significant information.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Hypokinesia, Pain in extremity, Skin infection
Clinical narrative: Skin Infection after falling; Fell down and hurt herself; Sore left arm; Could not lift arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm), HYPOKINESIA (Could not lift arm), SKIN INFECTION (Skin Infection after falling) and FALL (Fell down and hurt herself) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm) and HYPOKINESIA (Could not lift arm). On 16-Apr-2021, the patient experienced SKIN INFECTION (Skin Infection after falling) and FALL (Fell down and hurt herself). On 04-Apr-2021, PAIN IN EXTREMITY (Sore left arm) and HYPOKINESIA (Could not lift arm) had resolved. On 16-May-2021, FALL (Fell down and hurt herself) had resolved. At the time of the report, SKIN INFECTION (Skin Infection after falling) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.       Patient was prescribed antibiotics for skin infection.  No concomitant medications were reported.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered a dose of the Moderna vaccine to a patient from a vial that had been punctured for 19 hours; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna vaccine to a patient from a vial that had been punctured for 19 hours) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 038C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jul-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna vaccine to a patient from a vial that had been punctured for 19 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna vaccine to a patient from a vial that had been punctured for 19 hours) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Erythema, Injection site erythema, Myalgia, Pyrexia
Clinical narrative: Body ache; pyrexia; tachycardia; anxiety; below the site of injection was all red; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), ERYTHEMA (below the site of injection was all red), INJECTION SITE ERYTHEMA (injection site redness), ANXIETY (anxiety) and PYREXIA (pyrexia) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ERYTHEMA (below the site of injection was all red) and INJECTION SITE ERYTHEMA (injection site redness). On 06-Jul-2021, the patient experienced ANXIETY (anxiety). On an unknown date, the patient experienced MYALGIA (Body ache), PYREXIA (pyrexia) and TACHYCARDIA (tachycardia). On 10-May-2021, ERYTHEMA (below the site of injection was all red) had resolved. At the time of the report, MYALGIA (Body ache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Concomitant  medications were reported.   Treatment information was not provided.   This case was linked to MOD-2021-248714 (Patient Link).
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Body ache; pyrexia; tachycardia; anxiety; below the site of injection was all red; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), ERYTHEMA (below the site of injection was all red), INJECTION SITE ERYTHEMA (injection site redness), ANXIETY (anxiety) and PYREXIA (pyrexia) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ERYTHEMA (below the site of injection was all red) and INJECTION SITE ERYTHEMA (injection site redness). On 06-Jul-2021, the patient experienced ANXIETY (anxiety). On an unknown date, the patient experienced MYALGIA (Body ache), PYREXIA (pyrexia) and TACHYCARDIA (tachycardia). On 10-May-2021, ERYTHEMA (below the site of injection was all red) had resolved. At the time of the report, MYALGIA (Body ache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Concomitant  medications were reported.   Treatment information was not provided.   This case was linked to MOD-2021-248714 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 92 days out from first dose and has not yet received his second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (92 days out from first dose and has not yet received his second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (92 days out from first dose and has not yet received his second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (92 days out from first dose and has not yet received his second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was reported.   Reporter did not allow further contact
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Body temperature, Feeling abnormal, Feeling hot, Heart rate
Clinical narrative: Got very sick; Fever almost 104; Feel something different in body; Body was warm; Tonsil area was swollen; Having panic and anxiety; Panic; Sweating a lot / sweating a lot in my armpits; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLAR HYPERTROPHY (Tonsil area was swollen), HYPERHIDROSIS (Sweating a lot / sweating a lot in my armpits), ANXIETY (Having panic and anxiety), PANIC REACTION (Panic) and FEELING ABNORMAL (Feel something different in body) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced HYPERHIDROSIS (Sweating a lot / sweating a lot in my armpits). On 06-Jul-2021, the patient experienced ANXIETY (Having panic and anxiety) and PANIC REACTION (Panic). On an unknown date, the patient experienced TONSILLAR HYPERTROPHY (Tonsil area was swollen), FEELING ABNORMAL (Feel something different in body), FEELING HOT (Body was warm), ILLNESS (Got very sick) and PYREXIA (Fever almost 104). At the time of the report, TONSILLAR HYPERTROPHY (Tonsil area was swollen), HYPERHIDROSIS (Sweating a lot / sweating a lot in my armpits), ANXIETY (Having panic and anxiety), PANIC REACTION (Panic), FEELING ABNORMAL (Feel something different in body), FEELING HOT (Body was warm), ILLNESS (Got very sick) and PYREXIA (Fever almost 104) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, Body temperature: 104 (High) Fever almost 104. In June 2021, Heart rate: 130 (abnormal) rapid heartbeat maybe 130.         No concomitant medication were reported. No treatment information was reported.    This case was linked to MOD-2021-248640 (Patient Link).   Reporter did not allow further contact
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Illness, Panic reaction, Pyrexia, Tonsillar hypertrophy
Clinical narrative: Got very sick; Fever almost 104; Feel something different in body; Body was warm; Tonsil area was swollen; Having panic and anxiety; Panic; Sweating a lot / sweating a lot in my armpits; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLAR HYPERTROPHY (Tonsil area was swollen), HYPERHIDROSIS (Sweating a lot / sweating a lot in my armpits), ANXIETY (Having panic and anxiety), PANIC REACTION (Panic) and FEELING ABNORMAL (Feel something different in body) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jun-2021, the patient experienced HYPERHIDROSIS (Sweating a lot / sweating a lot in my armpits). On 06-Jul-2021, the patient experienced ANXIETY (Having panic and anxiety) and PANIC REACTION (Panic). On an unknown date, the patient experienced TONSILLAR HYPERTROPHY (Tonsil area was swollen), FEELING ABNORMAL (Feel something different in body), FEELING HOT (Body was warm), ILLNESS (Got very sick) and PYREXIA (Fever almost 104). At the time of the report, TONSILLAR HYPERTROPHY (Tonsil area was swollen), HYPERHIDROSIS (Sweating a lot / sweating a lot in my armpits), ANXIETY (Having panic and anxiety), PANIC REACTION (Panic), FEELING ABNORMAL (Feel something different in body), FEELING HOT (Body was warm), ILLNESS (Got very sick) and PYREXIA (Fever almost 104) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, Body temperature: 104 (High) Fever almost 104. In June 2021, Heart rate: 130 (abnormal) rapid heartbeat maybe 130.         No concomitant medication were reported. No treatment information was reported.    This case was linked to MOD-2021-248640 (Patient Link).   Reporter did not allow further contact
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator sincr 04 Jun 2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was reported.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Headache, Influenza like illness
Clinical narrative: He has a problem with his sense of smell and taste; he has a problem with his sense of smell and taste/has a weird sense of taste in his mouth; Fever; Heachache; Chills; Flu like symptoms; Stuffy nose; Sore throat; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), NASAL CONGESTION (Stuffy nose), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose) and ANOSMIA (He has a problem with his sense of smell and taste) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), NASAL CONGESTION (Stuffy nose), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), PYREXIA (Fever), HEADACHE (Heachache) and CHILLS (Chills). On an unknown date, the patient experienced ANOSMIA (He has a problem with his sense of smell and taste) and AGEUSIA (he has a problem with his sense of smell and taste/has a weird sense of taste in his mouth). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), NASAL CONGESTION (Stuffy nose), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), ANOSMIA (He has a problem with his sense of smell and taste), AGEUSIA (he has a problem with his sense of smell and taste/has a weird sense of taste in his mouth), PYREXIA (Fever), HEADACHE (Heachache) and CHILLS (Chills) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: He has a problem with his sense of smell and taste; he has a problem with his sense of smell and taste/has a weird sense of taste in his mouth; Fever; Heachache; Chills; Flu like symptoms; Stuffy nose; Sore throat; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), NASAL CONGESTION (Stuffy nose), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose) and ANOSMIA (He has a problem with his sense of smell and taste) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jul-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), NASAL CONGESTION (Stuffy nose), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), PYREXIA (Fever), HEADACHE (Heachache) and CHILLS (Chills). On an unknown date, the patient experienced ANOSMIA (He has a problem with his sense of smell and taste) and AGEUSIA (he has a problem with his sense of smell and taste/has a weird sense of taste in his mouth). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), NASAL CONGESTION (Stuffy nose), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose), ANOSMIA (He has a problem with his sense of smell and taste), AGEUSIA (he has a problem with his sense of smell and taste/has a weird sense of taste in his mouth), PYREXIA (Fever), HEADACHE (Heachache) and CHILLS (Chills) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient who received the 1st dose of the Moderna vaccine on 13May2021 and hasn't received the 2nd dose yet; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient who received the 1st dose of the Moderna vaccine on 13May2021 and hasn't received the 2nd dose yet) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient who received the 1st dose of the Moderna vaccine on 13May2021 and hasn't received the 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient who received the 1st dose of the Moderna vaccine on 13May2021 and hasn't received the 2nd dose yet) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. No concomitant medications reported. No treatment information was provided.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Autoscopy, Feeling abnormal, Memory impairment
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brain fog), AUTOSCOPY (Out of body experience) and MEMORY IMPAIRMENT (Second guessing where he was/ memory issues) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), ALBUTEROL SULFATE, NAPROXEN SODIUM (ALEVE), MONTELUKAST, OMEPRAZOLE and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication. On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced FEELING ABNORMAL (Brain fog), AUTOSCOPY (Out of body experience) and MEMORY IMPAIRMENT (Second guessing where he was/ memory issues). On 24-Jun-2021, FEELING ABNORMAL (Brain fog), AUTOSCOPY (Out of body experience) and MEMORY IMPAIRMENT (Second guessing where he was/ memory issues) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow-up received on 27 Jun 2021 contains no new information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Arm soreness; very tired; joint pain in most joints; My shots were given 12 weeks apart; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm soreness), FATIGUE (very tired), ARTHRALGIA (joint pain in most joints) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My shots were given 12 weeks apart) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Bee sting hypersensitivity (entire body covered in hives, severe itching, very low blood pressure, almost fainted, treated at ER) since 30-Jul-2015, Penicillin allergy (Dicloxacillin, difficulty swallowing) since 24-Oct-1996, Hypertension since 01-May-1999, Allergy to antibiotic (Cipro, thigh muscle pain) since 2002 and Drug allergy (Rosuvastatin,neck pain, itchy rash on leg) since 15-Apr-2021. Concomitant products included LORATADINE (CLARITIN [LORATADINE]) from 28-Apr-2021 to an unknown date and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 29-Apr-2021 to an unknown date for Anaphylaxis prophylaxis, ASCORBIC ACID, CUPRIC OXIDE, DL-ALPHA TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC OXIDE (PRESERVISION AREDS 2) from 01-Jun-2010 to an unknown date for Eye disorder NOS, BENAZEPRIL HCL from 15-Jan-2016 to an unknown date and HYDROCHLOROTHIAZIDE from 15-Jan-2016 to an unknown date for Hypertension.   On 04-Feb-2021 at 11:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021 at 7:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My shots were given 12 weeks apart). On 01-May-2021, the patient experienced MYALGIA (Arm soreness), FATIGUE (very tired) and ARTHRALGIA (joint pain in most joints). On 30-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (My shots were given 12 weeks apart) had resolved. At the time of the report, MYALGIA (Arm soreness), FATIGUE (very tired) and ARTHRALGIA (joint pain in most joints) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient complained of arm soreness, felt very tired and experienced joint pain in most joints for a few hours before she went to bed.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-018404 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects only lasted for two days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects only lasted for two days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects only lasted for two days). At the time of the report, VACCINATION COMPLICATION (side effects only lasted for two days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment details were reported.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Herpes simplex, Infection
Clinical narrative: Herpes simplex; Infection; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES SIMPLEX (Herpes simplex) and INFECTION (Infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Herpes simplex (She stated that over the years she had this medication once and has a history of herpes simplex 1.5 - 2 years ago).   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES SIMPLEX (Herpes simplex) and INFECTION (Infection). At the time of the report, HERPES SIMPLEX (Herpes simplex) and INFECTION (Infection) outcome was unknown.            Description of Event or Problem: The patient stated that she has been prescribed antibiotic in July for Valacyclovir (Valtrex) which is an anti-viral medication for herpes simplex outbreak per the patient. The patient has not yet taken antibiotic yet.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. The concomitant history was not reported. The treatment history was not provided. patient received expired dose of moderna vaccine.